SMD — Spectral MD Holdings Share Price
Last trade - 00:00- £79.69m
- £69.15m
- $25.37m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.24 | ||
| Price to Tang. Book | 6.24 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.95 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.45% | ||
| Return on Equity | -22.62% | ||
| Operating Margin | -10.43% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 5.85 | 17.3 | 15.24 | 25.37 | 26.61 | 41.26 | 63.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Spectral MD Holdings, Ltd. is a predictive artificial intelligence (AI) company. The Company develops technology using predictive analytics and AI algorithms to help clinicians in making faster treatment decisions in the wound care sector. The Company's DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The Company’s DeepView SnapShot wound imaging device is an internally developed multispectral imaging device, which enables the Company to distinguish between damaged and healthy human tissue invisible to the naked eye, providing day one healing assessments for burn wounds and diabetic foot ulcers (DFU). DeepView’s output is engineered to allow the physician to make an informed decision regarding the treatment of the patient’s wound. Its wholly owned subsidiary is Spectral MD UK Ltd.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- December 4th, 2020
- Public Since
- June 22nd, 2021
- No. of Employees
- 71
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 136,201,515
- Address
- 2515 McKinney Ave.,, Suite 1000,, DALLAS, 75201
- Web
- https://www.spectralmd.com/
- Phone
- +1 3026587581
- Auditors
- KPMG LLP
Latest News for SMD
Upcoming Events for SMD
Half Year 2023 Spectral MD Holdings Ltd Earnings Release
Similar to SMD
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Advanced Oncotherapy
London Stock Exchange
Angle
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 19:21 UTC, shares in Spectral MD Holdings are trading at 42.50p. This share price information is delayed by 15 minutes.
Shares in Spectral MD Holdings last closed at 42.50p and the price had moved by +19.72% over the past 365 days. In terms of relative price strength the Spectral MD Holdings share price has outperformed the FTSE All Share Index by +15.91% over the past year.
The overall consensus recommendation for Spectral MD Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Spectral MD Holdings does not currently pay a dividend.
Spectral MD Holdings does not currently pay a dividend.
Spectral MD Holdings does not currently pay a dividend.
To buy shares in Spectral MD Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 42.50p, shares in Spectral MD Holdings had a market capitalisation of £57.89m.
Here are the trading details for Spectral MD Holdings:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: SMD
Based on an overall assessment of its quality, value and momentum Spectral MD Holdings is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Spectral MD Holdings is 165.69p. That is 289.87% above the last closing price of 42.50p.
Analysts covering Spectral MD Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$0.07 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Spectral MD Holdings. Over the past six months, its share price has outperformed the FTSE All Share Index by +29.19%.
As of the last closing price of 42.50p, shares in Spectral MD Holdings were trading +17.4% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Spectral MD Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 42.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Spectral MD Holdings' directors